WIRB-Copernicus Group to Host Biosafety Management Webinar to Help Improve Oversight of Research with Biological Materials
This session will propose practical solutions to real-world biosafety issues
PRINCETON, N.J., Oct. 30, 2015 /PRNewswire/ -- WIRB-Copernicus Group® (WCG™), the world's largest provider of regulatory and ethical review services and software to support clinical research, today announced that it will be hosting a webinar, entitled: "Biosafety Program Oversight in 2015: Managing New Challenges with Limited Resources," from 3-4 p.m. ET on Tuesday, Nov. 3. WCG intends to continue the positive momentum generated during October, the National Institutes of Health's Biosafety Stewardship Month and the annual conference of the American Biological Safety Association, International.
"Recent high-profile incidents involving the mishandling of smallpox virus, and anthrax and plague bacteria have underscored the critical role that biosafety professionals play in safeguarding bench research science along with clinical trial participants and their families, researchers, and the local community," said WCG Chairman and Chief Executive Officer Donald A. Deieso, PhD. "We are pleased to gather thought leaders on biosafety practices and exchange knowledge of advanced biosafety training methods and standard operating procedures with other industry professionals to enhance the quality of Institutional Biosafety Committee (IBC) reviews and increase transparency in research with biological materials."
"As basic sciences and clinical research continue to evolve at a rapid rate, biosafety oversight programs are having to acquire additional areas of expertise. These increased oversight requirements can strain already limited IBC and biosafety program resources," said webinar host, Chris Jenkins, PhD, MPH, RBP, CHMM, senior vice president of biosafety and gene therapy at WCG Biosafety, a WCG division. "This webinar will address the latest challenges that biosafety programs face and offer practical solutions to help overcome them," he added.
The webinar presenters will be Marian Downing, RBP, CBSP, SM (NRCM), immediate past-president of the American Biological Safety Association (ABSA), and Martha Schneerman, PhD, CBSP, SM (NRCM), a member of the ABSA Credential Maintenance Board.
To register for this complimentary webinar, please visit https://goto.webcasts.com/starthere.jsp?ei=1079968.
Dr. Jenkins has also co-authored a white paper with Currien MacDonald, MD, CIP, Institutional Review Board (IRB) Chair at Western IRB, a WCG company. The paper is entitled: "Best Practices: The Necessary Integration of IRB and IBCs," which the company is also making available.
Currently, there are no regulatory requirements governing the integration or coordination of IRB and IBC reviews. However, if these processes are not well integrated, communication between the committees will be impaired, potentially resulting in confusion or delays. It could even necessitate a re-review by one or both committees. This paper seeks to demonstrate how, with a change in perspective and effective management, the required dual review can create opportunities to improve the quality of both reviews.
To request a copy of this white paper, please visit http://www.wcgclinical.com/practices-integration-independent-review-boards-institutional-biosafety-committee-review.
About WIRB-Copernicus Group
WIRB-Copernicus Group (WCG) is the world's largest provider of regulatory and ethical solutions for clinical research. The company provides Institutional Review Board (IRB) and Institutional Biosafety Committee (IBC) reviews, and Human Research Protections (HRP), Good Clinical Practice (GCP) and Biosafety consulting services. Its technology offerings include IRB workflow management solutions (IRBNet), clinical trial management software for sponsors and contract research organizations (ePharmaSolutions), and Part-11 compliant online learning solutions for research professionals (WCG Academy).
The pioneer of independent ethical oversight, WCG continues to drive progress in the clinical research space. WCG empowers clients to accelerate life-saving advancements, while ensuring that the risks of progress never outweigh the value of human life.
For more information, please visit www.wcgclinical.com or follow us on Twitter @WCGClinical.
Photo - http://photos.prnewswire.com/prnh/20140422/77410
SOURCE WIRB-Copernicus Group
Share this article